Skip to content

Reliability, Sensitivity and Validity of the 6 Minute Step Test in Chronic Obstructive Pulmonary Disease (COPD) Patients

Evaluation of Reliability, Sensitivity and Validity of the Six Minute Step Test in Patients With Chronic Obstructive Pulmonary Disease and Its Relation With Predictors Markers of Risk of Death

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01298661
Enrollment
91
Registered
2011-02-18
Start date
2011-02-28
Completion date
2012-12-31
Last updated
2013-11-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease

Keywords

Exercise Test, Reproducibility of Results, Mortality

Brief summary

Chronic Obstructive Pulmonary Disease (COPD) leads to a reduction in exercise capacity that affects the quality of life and increases mortality of these patients. So, exercise tests are considered as an essential component of the clinical evaluation of the patients with COPD. The objective of this study is to evaluate the reproducibility sensitivity and validity of the Six Minute Step Test (6MST) in patients with COPD and in health volunteers, and verify its relation with the Body-Mass Index, Airways Obstruction, Dyspnea and Exercise Capacity Index (BODE). This Observational, Transversal, Prospective study will be conducted in the Special Unit of Respiratory Physiotherapy, of the Federal University of São Carlos. To participate in this study, 120 subjects, both gender, will be invited and will be allocated in five groups: Group I (30 healthy young subjects of 17 to 27 years old), Group II (30 healthy elderly individuals of 60 to 75 years old), and patients COPD, 60 to 80 years old, with mild, moderate, severe and very severe obstruction determined by the forced expiratory volume in one second (FEV1) by forced vital capacity (FVC) relation FEV1/FVC \<70% and FEV1 in predict percentage \< 80% composing the Group III (20 COPD patients in GOLD stage I), Group IV (20 COPD patients in GOLD stage II) and Group V (20 patients COPD stages III and IV). All subjects will be submitted to body composition and anthropometric assessment, pulmonary function test, three 6-minutes walk test (6MWT) and three 6MST. Furthermore, the patients of the groups III, IV and V will answer the Modified Medical Research Council (mMRC) scale, and BODE index will be calculated to each of them.

Interventions

The patients underwent a test where they need to step up and down a 20cm test during six minutes.

Sponsors

Conselho Nacional de Desenvolvimento Científico e Tecnológico
CollaboratorOTHER_GOV
Universidade Federal de Sao Carlos
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* Young and elderly healthy subjects presented pulmonary function within the normal range, confirmed by spirometry * Patients with clinical and spirometric diagnosis of COPD

Exclusion criteria

* Lung disease exacerbated * Decompensated heart disease * Rheumatic, neurological or orthopedic disease, preventing them from doing the tests by limiting the exercise * Peripheral oxygen saturation \< 80% without physical effort * Subjects who does not complete the first day of evaluation

Design outcomes

Primary

MeasureTime frameDescription
First Six Minute Step Test PerformanceFirst day or second day of the protocol (random)This test will be conducted by the Rater 1, the patient will step up and down a 20cm step during six minute. The performance will be evaluated by the number of the steps.
Second Six Minute Step Test PerformanceOn the first or second day of evaluation (random), 30 minutes after the first 6MST.This test will be conducted by the Rater 1, the patient will step up and down a 20cm step during six minutes. The performance will be evaluated by the number of the climbs.
Third Six Minute Step Test PerformanceOn the third day of evaluation, seven days after the first day of evaluation. Since it was performed in the same day of the third 6MWT, the choice of the first test was random, and there was a 30 minute interval between them.This test will be conducted by the Rater 2, the patient will step up and down a 20cm step during six minutes. The performance will be evaluated by the number of the climbs.

Secondary

MeasureTime frameDescription
Body-Mass Index, Airflow Obstruction, Dyspnea, Exercise Capacity Index (BODE Index)Second dayIt was evaluated only in the COPD patients. BODE index is a prognostic index used in COPD patients, it is a 0-10 scale, where lower values means better prognostic. It is composed by other commonly used evaluations tools in COPD, Forced Expiratory Volume in the First second (from spirometry); classification in the scale ranging from 0-3, Body-mass index, classification in the scale ranging from 0-1; Six-minute walk test distance, classification in the scale ranging from 0-3 and referred dyspnea, classification in the scale ranging from 0-3. It was only used the total score (0-10)
First Six Minute Walk Test Exertion PerceptionFirst day or second day of the protocol (random)This test was conducted by the Rater 1, the subject walked as far as it could in a 30m corridor during 6 minutes. The Exertion Perception will be evaluated using BORG scale. This scale is a self-reported scale, which range from 0 to 10, where 0 means none exertion perception and 10 means very intense exertion perception (the highest the patient has ever felt). Lower values means that the patient feel less discomfort.
Second Six Minute Walk Test Exertion PerceptionFirst day or second day of the protocol (random), 30 minutes after the first 6MWTThis test will be conducted by the Rater 1, the subject will walk as far as it can in a 30m corridor during 6 minutes. The Exertion Perception will be evaluated using BORG scale. This scale is a self-reported scale, which range from 0 to 10, where 0 means none exertion perception and 10 means very intense exertion perception (the highest the patient has ever felt). Lower values means that the patient feel less discomfort.
Third Six Minute Walk Test Exertion PerceptionOn the third day of evaluation, seven days after the first day of evaluation. Since it was performed in the same day of the third 6MST, the choice of the first test was random, and there was a 30 minute interval between them.This test will be conducted by the Rater 2, the subject will walk as far as it can in a 30m corridor during 6 minutes. The Exertion Perception will be evaluated using BORG scale. This scale is a self-reported scale, which range from 0 to 10, where 0 means none exertion perception and 10 means very intense exertion perception (the highest the patient has ever felt). Lower values means that the patient feel less discomfort.
First Six Minute Step Test Exertion PerceptionFirst day or second day of the protocol (random)This test will be conducted by the Rater 1, the patient will step up and down one 20cm step during six minute. The Exertion Perception will be evaluated using BORG scale. This scale is a self-reported scale, which range from 0 to 10, where 0 means none exertion perception and 10 means very intense exertion perception (the highest the patient has ever felt). Lower values means that the patient feel less discomfort.
Second Six Minute Step Test Exertion PerceptionFirst day or second day of the protocol (random), 30 minutes after the first 6MSTThis test will be conducted by the Rater 1, the patient will step up and down one 20cm step during six minute.The Exertion Perception will be evaluated using BORG scale. This scale is a self-reported scale, which range from 0 to 10, where 0 means none exertion perception and 10 means very intense exertion perception (the highest the patient has ever felt). Lower values means that the patient feel less discomfort.
Third Six Minute Step Test Exertion PerceptionOn the third day of evaluation, seven days after the first day of evaluation. Since it was performed in the same day of the third 6MWT, the choice of the first test was random, and there was a 30 minute interval between them.This test will be conducted by the Rater 2, the patient will step up down one 20cm step during six minute. The Exertion Perception will be evaluated using BORG scale. This scale is a self-reported scale, which range from 0 to 10, where 0 means none exertion perception and 10 means very intense exertion perception (the highest the patient has ever felt). Lower values means that the patient feel less discomfort.
First Six Minute Walk Test Peripheral Oxygen SaturationFirst day or second day of the protocol (random)This test will be conducted by the Rater 1, the subject will walk as far as it can in a 30m corridor during 6 minutes. It will be evaluated by a pulse oxymeter.
Second Six Minute Walk Test Peripheral Oxygen Saturation,First day or second day of the protocol (random) 30 minutes after the first 6MWTThis test will be conducted by the Rater 1, the subject will walk as far as it can in a 30m corridor during 6 minutes. It will be evaluated by a pulse oxymeter.
First Six Minute Walk Test DistanceFirst day or second day of the protocol (random)This test will be conducted by the Rater 1, the subject will walk as far as it can in a 30m corridor during 6 minutes. The performance will be the distance (meters)that it walk.
First Six Minute Step Test Peripheral Oxygen SaturationFirst day or second day of the protocol (random)This test will be conducted by the Rater 1, the patient will step up and down one 20cm step during six minute. It will be evaluated by a pulse oxymeter.
Second Six Minute Step Test Peripheral Oxygen SaturationFirst day or second day of the protocol (random) ,30 minutes after the first 6MSTThis test will be conducted by the Rater 1, the patient will step up and down one 20cm step during six minute. It will be evaluated by a pulse oxymeter .
Third Six Minute Step Test Peripheral Oxygen SaturationOn the third day of evaluation, seven days after the first day of evaluation. Since it was performed in the same day of the third 6MWT, the choice of the first test was random, and there was a 30 minute interval between them.This test will be conducted by the Rater 2, the patient will step up and down one 20cm step during six minute. It will be evaluated by a pulse oxymeter.
First Six Minute Walk Test Heart RateFirst day or second day of the protocol (random)This test will be conducted by the Rater 1, the subject will walk as far as it can in a 30m corridor during 6 minutes. It will be evaluated by a cardio monitor.
Second Six Minute Walk Test Heart RateFirst day or second day of the protocol (random), 30 minutes after the first 6MWTThis test will be conducted by the Rater 1, the subject will walk as far as it can in a 30m corridor during 6 minutes. It will be evaluated by a cardio monitor at rest and every two minutes of the test.
Third Six Minute Walk Test Heart RateOn the third day of evaluation, seven days after the first day of evaluation. Since it was performed in the same day of the third 6MST, the choice of the first test was random, and there was a 30 minute interval between them.This test will be conducted by the Rater 2, the subject will walk as far as it can in a 30m corridor during 6 minutes. It will be evaluated by a cardio monitor.
First Six Minute Step Test Heart RateFirst day or second day of the protocol (random)This test will be conducted by the Rater 1, the patient will step up and down a 20cm step during six minute. It will be evaluated by a cardio monitor.
Second Six Minute Step Test Heart RateFirst day or second day of the protocol (random), 30 minutes after the first 6MSTThis test will be conducted by the Rater 1, the patient will step up and down a 20cm step during six minute. It will be evaluated by a cardio monitor.
Third Six Minute Step Test Heart RateOn the third day of evaluation, seven days after the first day of evaluation. Since it was performed in the same day of the third 6MWT, the choice of the first test was random, and there was a 30 minute interval between them.This test will be conducted by the Rater 2, the patient will step up and down a 20cm step during six minute. It will be evaluated by a cardio monitor.
Third Six Minute Walk Test Peripheral Oxygen SaturationOn the third day of evaluation, seven days after the first day of evaluation. Since it was performed in the same day of the third 6MST, the choice of the first test was random, and there was a 30 minute interval between them.This test will be conducted by the Rater 2, the subject will walk as far as it can in a 30m corridor during 6 minutes. It will be evaluated by a pulse oxymeter.
Second Six Minute Walk Test DistanceOn the first or second day of evaluation (random), 30 minutes after the first 6MWT.This test will be conducted by the Rater 1, the subject will walk as far as it can in a 30m corridor during 6 minutes. The performance will be the distance (meters)that it walk.
Third Six Minute Walk Test DistanceOn the third day of evaluation, seven days after the first day of evaluation. Since it was performed in the same day of the third 6MST, the choice of the first test was random, and there was a 30 minute interval between them.This test will be conducted by the Rater 2, the subject will walk as far as it can in a 30m corridor during 6 minutes. The performance will be the distance (meters)that it walk.

Countries

Brazil

Participant flow

Recruitment details

The recruitment occurred from February 2011 until July 2012. The COPD patients were those referred to pulmonary rehabilitation on Unidade Especial de Fisioterapia Respiratória and the health individuals were recruited by invitation using posters on the University region.

Participants by arm

ArmCount
Healthy Young Subjects
Subjects apparently healthy, with age of 18 to 27 years old.
31
Healthy Elderly Subjects
Subjects apparently healthy, with age of 60 to 75 years old.
24
COPD Patients
Patients with clinical and spirometric diagnosis of COPD
32
Total87

Withdrawals & dropouts

PeriodReasonFG000FG001FG002
Overall StudyWithdrawal by Subject202

Baseline characteristics

CharacteristicHealthy Elderly SubjectsCOPD PatientsHealthy Young SubjectsTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
18 Participants23 Participants0 Participants41 Participants
Age, Categorical
Between 18 and 65 years
6 Participants9 Participants31 Participants46 Participants
Age Continuous68.9 years
STANDARD_DEVIATION 6.75
68.6 years
STANDARD_DEVIATION 10.3
22.7 years
STANDARD_DEVIATION 2.52
52.3 years
STANDARD_DEVIATION 23.3
Region of Enrollment
Brazil
24 participants32 participants31 participants87 participants
Sex: Female, Male
Female
12 Participants8 Participants15 Participants35 Participants
Sex: Female, Male
Male
12 Participants24 Participants16 Participants52 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —
other
Total, other adverse events
0 / 00 / 00 / 0
serious
Total, serious adverse events
0 / 00 / 00 / 0

Outcome results

Primary

First Six Minute Step Test Performance

This test will be conducted by the Rater 1, the patient will step up and down a 20cm step during six minute. The performance will be evaluated by the number of the steps.

Time frame: First day or second day of the protocol (random)

Population: 2 COPD patients and 2 healthy young individuals were excluded since they did not appeared in the second day of evaluation.

ArmMeasureValue (MEAN)Dispersion
Healthy Young SubjectsFirst Six Minute Step Test Performance166.4 stepsStandard Deviation 36.4
Healthy Elderly SubjectsFirst Six Minute Step Test Performance114.0 stepsStandard Deviation 29.2
COPD PatientsFirst Six Minute Step Test Performance76.6 stepsStandard Deviation 19.6
Primary

Second Six Minute Step Test Performance

This test will be conducted by the Rater 1, the patient will step up and down a 20cm step during six minutes. The performance will be evaluated by the number of the climbs.

Time frame: On the first or second day of evaluation (random), 30 minutes after the first 6MST.

Population: 2 COPD patients and 2 healthy young individuals were excluded since they did not appeared in the second day of evaluation.

ArmMeasureValue (MEAN)Dispersion
Healthy Young SubjectsSecond Six Minute Step Test Performance170.7 stepsStandard Deviation 40.6
Healthy Elderly SubjectsSecond Six Minute Step Test Performance114.5 stepsStandard Deviation 33.5
COPD PatientsSecond Six Minute Step Test Performance82.4 stepsStandard Deviation 20.7
Primary

Third Six Minute Step Test Performance

This test will be conducted by the Rater 2, the patient will step up and down a 20cm step during six minutes. The performance will be evaluated by the number of the climbs.

Time frame: On the third day of evaluation, seven days after the first day of evaluation. Since it was performed in the same day of the third 6MWT, the choice of the first test was random, and there was a 30 minute interval between them.

Population: 2 COPD patients and 2 healthy young individuals were excluded from the study since they did not appeared in the second day of evaluation. 3 COPD patient Analysis Population Description: s and 5 elderly subjects didn't show on the third day of evaluation, then, they were just excluded in the analysis of the variables collected in this day.

ArmMeasureValue (MEAN)Dispersion
Healthy Young SubjectsThird Six Minute Step Test Performance172.3 stepsStandard Deviation 36.3
Healthy Elderly SubjectsThird Six Minute Step Test Performance111.3 stepsStandard Deviation 32.9
COPD PatientsThird Six Minute Step Test Performance86.4 stepsStandard Deviation 22
Secondary

Body-Mass Index, Airflow Obstruction, Dyspnea, Exercise Capacity Index (BODE Index)

It was evaluated only in the COPD patients. BODE index is a prognostic index used in COPD patients, it is a 0-10 scale, where lower values means better prognostic. It is composed by other commonly used evaluations tools in COPD, Forced Expiratory Volume in the First second (from spirometry); classification in the scale ranging from 0-3, Body-mass index, classification in the scale ranging from 0-1; Six-minute walk test distance, classification in the scale ranging from 0-3 and referred dyspnea, classification in the scale ranging from 0-3. It was only used the total score (0-10)

Time frame: Second day

Population: 2 COPD were excluded since they did not appeared in the second day of evaluation. The other two populations were not verified, since the measure is specific for COPD patients

ArmMeasureValue (MEDIAN)
Healthy Young SubjectsBody-Mass Index, Airflow Obstruction, Dyspnea, Exercise Capacity Index (BODE Index)3 units on a scale
Secondary

First Six Minute Step Test Exertion Perception

This test will be conducted by the Rater 1, the patient will step up and down one 20cm step during six minute. The Exertion Perception will be evaluated using BORG scale. This scale is a self-reported scale, which range from 0 to 10, where 0 means none exertion perception and 10 means very intense exertion perception (the highest the patient has ever felt). Lower values means that the patient feel less discomfort.

Time frame: First day or second day of the protocol (random)

Population: 2 COPD patients and 2 healthy young individuals were excluded since they did not appeared in the second day of evaluation.

ArmMeasureValue (MEDIAN)
Healthy Young SubjectsFirst Six Minute Step Test Exertion Perception2 units on a scale
Healthy Elderly SubjectsFirst Six Minute Step Test Exertion Perception2.5 units on a scale
COPD PatientsFirst Six Minute Step Test Exertion Perception2 units on a scale
Secondary

First Six Minute Step Test Heart Rate

This test will be conducted by the Rater 1, the patient will step up and down a 20cm step during six minute. It will be evaluated by a cardio monitor.

Time frame: First day or second day of the protocol (random)

Population: 2 COPD patients and 2 healthy young individuals were excluded since they did not appeared in the second day of evaluation.

ArmMeasureValue (MEAN)Dispersion
Healthy Young SubjectsFirst Six Minute Step Test Heart Rate154 bpmStandard Deviation 11
Healthy Elderly SubjectsFirst Six Minute Step Test Heart Rate116 bpmStandard Deviation 11
COPD PatientsFirst Six Minute Step Test Heart Rate117 bpmStandard Deviation 10
Secondary

First Six Minute Step Test Peripheral Oxygen Saturation

This test will be conducted by the Rater 1, the patient will step up and down one 20cm step during six minute. It will be evaluated by a pulse oxymeter.

Time frame: First day or second day of the protocol (random)

Population: 2 COPD patients and 2 healthy young individuals were excluded since they did not appeared in the second day of evaluation.

ArmMeasureValue (MEAN)Dispersion
Healthy Young SubjectsFirst Six Minute Step Test Peripheral Oxygen Saturation95.8 % of hemoglobinStandard Deviation 1.3
Healthy Elderly SubjectsFirst Six Minute Step Test Peripheral Oxygen Saturation95 % of hemoglobinStandard Deviation 1.9
COPD PatientsFirst Six Minute Step Test Peripheral Oxygen Saturation90.1 % of hemoglobinStandard Deviation 3.9
Secondary

First Six Minute Walk Test Distance

This test will be conducted by the Rater 1, the subject will walk as far as it can in a 30m corridor during 6 minutes. The performance will be the distance (meters)that it walk.

Time frame: First day or second day of the protocol (random)

Population: 2 COPD patients and 2 healthy young individuals were excluded since they did not appeared in the second day of evaluation.

ArmMeasureValue (MEAN)Dispersion
Healthy Young SubjectsFirst Six Minute Walk Test Distance643.5 meterStandard Deviation 63.1
Healthy Elderly SubjectsFirst Six Minute Walk Test Distance504.5 meterStandard Deviation 119
COPD PatientsFirst Six Minute Walk Test Distance380.4 meterStandard Deviation 107.8
Secondary

First Six Minute Walk Test Exertion Perception

This test was conducted by the Rater 1, the subject walked as far as it could in a 30m corridor during 6 minutes. The Exertion Perception will be evaluated using BORG scale. This scale is a self-reported scale, which range from 0 to 10, where 0 means none exertion perception and 10 means very intense exertion perception (the highest the patient has ever felt). Lower values means that the patient feel less discomfort.

Time frame: First day or second day of the protocol (random)

Population: 2 COPD patients and 2 healthy young individuals were excluded since they did not appeared in the second day of evaluation.

ArmMeasureValue (MEDIAN)
Healthy Young SubjectsFirst Six Minute Walk Test Exertion Perception1 units on a scale
Healthy Elderly SubjectsFirst Six Minute Walk Test Exertion Perception0.5 units on a scale
COPD PatientsFirst Six Minute Walk Test Exertion Perception1 units on a scale
Secondary

First Six Minute Walk Test Heart Rate

This test will be conducted by the Rater 1, the subject will walk as far as it can in a 30m corridor during 6 minutes. It will be evaluated by a cardio monitor.

Time frame: First day or second day of the protocol (random)

Population: 2 COPD patients and 2 healthy young individuals were excluded since they did not appeared in the second day of evaluation.

ArmMeasureValue (MEAN)Dispersion
Healthy Young SubjectsFirst Six Minute Walk Test Heart Rate143 bpmStandard Deviation 15
Healthy Elderly SubjectsFirst Six Minute Walk Test Heart Rate115 bpmStandard Deviation 11
COPD PatientsFirst Six Minute Walk Test Heart Rate113 bpmStandard Deviation 11
Secondary

First Six Minute Walk Test Peripheral Oxygen Saturation

This test will be conducted by the Rater 1, the subject will walk as far as it can in a 30m corridor during 6 minutes. It will be evaluated by a pulse oxymeter.

Time frame: First day or second day of the protocol (random)

Population: 2 COPD patients and 2 healthy young individuals were excluded since they did not appeared in the second day of evaluation.

ArmMeasureValue (MEAN)Dispersion
Healthy Young SubjectsFirst Six Minute Walk Test Peripheral Oxygen Saturation96.7 % of hemoglobinStandard Deviation 1.3
Healthy Elderly SubjectsFirst Six Minute Walk Test Peripheral Oxygen Saturation94.5 % of hemoglobinStandard Deviation 1.7
COPD PatientsFirst Six Minute Walk Test Peripheral Oxygen Saturation90.4 % of hemoglobinStandard Deviation 3.15
Secondary

Second Six Minute Step Test Exertion Perception

This test will be conducted by the Rater 1, the patient will step up and down one 20cm step during six minute.The Exertion Perception will be evaluated using BORG scale. This scale is a self-reported scale, which range from 0 to 10, where 0 means none exertion perception and 10 means very intense exertion perception (the highest the patient has ever felt). Lower values means that the patient feel less discomfort.

Time frame: First day or second day of the protocol (random), 30 minutes after the first 6MST

Population: 2 COPD patients and 2 healthy young individuals were excluded since they did not appeared in the second day of evaluation.

ArmMeasureValue (MEDIAN)
Healthy Young SubjectsSecond Six Minute Step Test Exertion Perception2 units on a scale
Healthy Elderly SubjectsSecond Six Minute Step Test Exertion Perception1.5 units on a scale
COPD PatientsSecond Six Minute Step Test Exertion Perception2.5 units on a scale
Secondary

Second Six Minute Step Test Heart Rate

This test will be conducted by the Rater 1, the patient will step up and down a 20cm step during six minute. It will be evaluated by a cardio monitor.

Time frame: First day or second day of the protocol (random), 30 minutes after the first 6MST

Population: 2 COPD patients and 2 healthy young individuals were excluded since they did not appeared in the second day of evaluation.

ArmMeasureValue (MEAN)Dispersion
Healthy Young SubjectsSecond Six Minute Step Test Heart Rate159 bpmStandard Deviation 6.7
Healthy Elderly SubjectsSecond Six Minute Step Test Heart Rate118 bpmStandard Deviation 8.7
COPD PatientsSecond Six Minute Step Test Heart Rate117 bpmStandard Deviation 12
Secondary

Second Six Minute Step Test Peripheral Oxygen Saturation

This test will be conducted by the Rater 1, the patient will step up and down one 20cm step during six minute. It will be evaluated by a pulse oxymeter .

Time frame: First day or second day of the protocol (random) ,30 minutes after the first 6MST

Population: 2 COPD patients and 2 healthy young individuals were excluded since they did not appeared in the second day of evaluation.

ArmMeasureValue (MEAN)Dispersion
Healthy Young SubjectsSecond Six Minute Step Test Peripheral Oxygen Saturation96 % of hemoglobinStandard Deviation 1.6
Healthy Elderly SubjectsSecond Six Minute Step Test Peripheral Oxygen Saturation94.9 % of hemoglobinStandard Deviation 1.8
COPD PatientsSecond Six Minute Step Test Peripheral Oxygen Saturation90.5 % of hemoglobinStandard Deviation 2.8
Secondary

Second Six Minute Walk Test Distance

This test will be conducted by the Rater 1, the subject will walk as far as it can in a 30m corridor during 6 minutes. The performance will be the distance (meters)that it walk.

Time frame: On the first or second day of evaluation (random), 30 minutes after the first 6MWT.

Population: 2 COPD patients and 2 healthy young individuals were excluded since they did not appeared in the second day of evaluation.

ArmMeasureValue (MEAN)Dispersion
Healthy Young SubjectsSecond Six Minute Walk Test Distance648.2 meterStandard Deviation 81.9
Healthy Elderly SubjectsSecond Six Minute Walk Test Distance513.6 meterStandard Deviation 84.3
COPD PatientsSecond Six Minute Walk Test Distance391.0 meterStandard Deviation 94
Secondary

Second Six Minute Walk Test Exertion Perception

This test will be conducted by the Rater 1, the subject will walk as far as it can in a 30m corridor during 6 minutes. The Exertion Perception will be evaluated using BORG scale. This scale is a self-reported scale, which range from 0 to 10, where 0 means none exertion perception and 10 means very intense exertion perception (the highest the patient has ever felt). Lower values means that the patient feel less discomfort.

Time frame: First day or second day of the protocol (random), 30 minutes after the first 6MWT

Population: 2 COPD patients and 2 healthy young individuals were excluded since they did not appeared in the second day of evaluation.

ArmMeasureValue (MEDIAN)
Healthy Young SubjectsSecond Six Minute Walk Test Exertion Perception0.5 units on a scale
Healthy Elderly SubjectsSecond Six Minute Walk Test Exertion Perception0.5 units on a scale
COPD PatientsSecond Six Minute Walk Test Exertion Perception1 units on a scale
Secondary

Second Six Minute Walk Test Heart Rate

This test will be conducted by the Rater 1, the subject will walk as far as it can in a 30m corridor during 6 minutes. It will be evaluated by a cardio monitor at rest and every two minutes of the test.

Time frame: First day or second day of the protocol (random), 30 minutes after the first 6MWT

Population: 2 COPD patients and 2 healthy young individuals were excluded since they did not appeared in the second day of evaluation.

ArmMeasureValue (MEAN)Dispersion
Healthy Young SubjectsSecond Six Minute Walk Test Heart Rate144 bpmStandard Deviation 13
Healthy Elderly SubjectsSecond Six Minute Walk Test Heart Rate115 bpmStandard Deviation 9
COPD PatientsSecond Six Minute Walk Test Heart Rate112 bpmStandard Deviation 11
Secondary

Second Six Minute Walk Test Peripheral Oxygen Saturation

This test will be conducted by the Rater 1, the subject will walk as far as it can in a 30m corridor during 6 minutes. It will be evaluated by a pulse oxymeter.

Time frame: ,First day or second day of the protocol (random) 30 minutes after the first 6MWT

Population: 2 COPD patients and 2 healthy young individuals were excluded since they did not appeared in the second day of evaluation.

ArmMeasureValue (MEAN)Dispersion
Healthy Young SubjectsSecond Six Minute Walk Test Peripheral Oxygen Saturation96.4 % of hemoglobinStandard Deviation 1.81
Healthy Elderly SubjectsSecond Six Minute Walk Test Peripheral Oxygen Saturation95.1 % of hemoglobinStandard Deviation 1.48
COPD PatientsSecond Six Minute Walk Test Peripheral Oxygen Saturation90.3 % of hemoglobinStandard Deviation 3.33
Secondary

Third Six Minute Step Test Exertion Perception

This test will be conducted by the Rater 2, the patient will step up down one 20cm step during six minute. The Exertion Perception will be evaluated using BORG scale. This scale is a self-reported scale, which range from 0 to 10, where 0 means none exertion perception and 10 means very intense exertion perception (the highest the patient has ever felt). Lower values means that the patient feel less discomfort.

Time frame: On the third day of evaluation, seven days after the first day of evaluation. Since it was performed in the same day of the third 6MWT, the choice of the first test was random, and there was a 30 minute interval between them.

Population: 2 COPD patients and 2 healthy young individuals were excluded from the study since they did not appeared in the second day of evaluation. 3 COPD patient Analysis Population Description: s and 5 elderly subjects didn't show on the third day of evaluation, then, they were just excluded in the analysis of the variables collected in this day.

ArmMeasureValue (MEDIAN)
Healthy Young SubjectsThird Six Minute Step Test Exertion Perception1 units on a scale
Healthy Elderly SubjectsThird Six Minute Step Test Exertion Perception2 units on a scale
COPD PatientsThird Six Minute Step Test Exertion Perception2.5 units on a scale
Secondary

Third Six Minute Step Test Heart Rate

This test will be conducted by the Rater 2, the patient will step up and down a 20cm step during six minute. It will be evaluated by a cardio monitor.

Time frame: On the third day of evaluation, seven days after the first day of evaluation. Since it was performed in the same day of the third 6MWT, the choice of the first test was random, and there was a 30 minute interval between them.

Population: 2 COPD patients and 2 healthy young individuals were excluded from the study since they did not appeared in the second day of evaluation. 3 COPD patient Analysis Population Description: s and 5 elderly subjects didn't show on the third day of evaluation, then, they were just excluded in the analysis of the variables collected in this day.

ArmMeasureValue (MEAN)Dispersion
Healthy Young SubjectsThird Six Minute Step Test Heart Rate156 bpmStandard Deviation 11
Healthy Elderly SubjectsThird Six Minute Step Test Heart Rate117 bpmStandard Deviation 9.3
COPD PatientsThird Six Minute Step Test Heart Rate116 bpmStandard Deviation 15
Secondary

Third Six Minute Step Test Peripheral Oxygen Saturation

This test will be conducted by the Rater 2, the patient will step up and down one 20cm step during six minute. It will be evaluated by a pulse oxymeter.

Time frame: On the third day of evaluation, seven days after the first day of evaluation. Since it was performed in the same day of the third 6MWT, the choice of the first test was random, and there was a 30 minute interval between them.

Population: 2 COPD patients and 2 healthy young individuals were excluded from the study since they did not appeared in the second day of evaluation. 3 COPD patient Analysis Population Description: s and 5 elderly subjects didn't show on the third day of evaluation, then, they were just excluded in the analysis of the variables collected in this day.

ArmMeasureValue (MEAN)Dispersion
Healthy Young SubjectsThird Six Minute Step Test Peripheral Oxygen Saturation95.8 % of hemoglobinStandard Deviation 1.3
Healthy Elderly SubjectsThird Six Minute Step Test Peripheral Oxygen Saturation94.9 % of hemoglobinStandard Deviation 1.8
COPD PatientsThird Six Minute Step Test Peripheral Oxygen Saturation90.3 % of hemoglobinStandard Deviation 3.1
Secondary

Third Six Minute Walk Test Distance

This test will be conducted by the Rater 2, the subject will walk as far as it can in a 30m corridor during 6 minutes. The performance will be the distance (meters)that it walk.

Time frame: On the third day of evaluation, seven days after the first day of evaluation. Since it was performed in the same day of the third 6MST, the choice of the first test was random, and there was a 30 minute interval between them.

Population: 2 COPD patients and 2 healthy young individuals were excluded from the study since they did not appeared in the second day of evaluation. 3 COPD patient Analysis Population Description: s and 5 elderly subjects didn't show on the third day of evaluation, then, they were just excluded in the analysis of the variables collected in this day.

ArmMeasureValue (MEAN)Dispersion
Healthy Young SubjectsThird Six Minute Walk Test Distance648.3 meterStandard Deviation 73.9
Healthy Elderly SubjectsThird Six Minute Walk Test Distance502 meterStandard Deviation 112.4
COPD PatientsThird Six Minute Walk Test Distance392.4 meterStandard Deviation 93
Secondary

Third Six Minute Walk Test Exertion Perception

This test will be conducted by the Rater 2, the subject will walk as far as it can in a 30m corridor during 6 minutes. The Exertion Perception will be evaluated using BORG scale. This scale is a self-reported scale, which range from 0 to 10, where 0 means none exertion perception and 10 means very intense exertion perception (the highest the patient has ever felt). Lower values means that the patient feel less discomfort.

Time frame: On the third day of evaluation, seven days after the first day of evaluation. Since it was performed in the same day of the third 6MST, the choice of the first test was random, and there was a 30 minute interval between them.

Population: 2 COPD patients and 2 healthy young individuals were excluded from the study since they did not appeared in the second day of evaluation. 3 COPD patient Analysis Population Description: s and 5 elderly subjects didn't show on the third day of evaluation, then, they were just excluded in the analysis of the variables collected in this day.

ArmMeasureValue (MEDIAN)
Healthy Young SubjectsThird Six Minute Walk Test Exertion Perception1 units on a scale
Healthy Elderly SubjectsThird Six Minute Walk Test Exertion Perception1 units on a scale
COPD PatientsThird Six Minute Walk Test Exertion Perception2 units on a scale
Secondary

Third Six Minute Walk Test Heart Rate

This test will be conducted by the Rater 2, the subject will walk as far as it can in a 30m corridor during 6 minutes. It will be evaluated by a cardio monitor.

Time frame: On the third day of evaluation, seven days after the first day of evaluation. Since it was performed in the same day of the third 6MST, the choice of the first test was random, and there was a 30 minute interval between them.

Population: 2 COPD patients and 2 healthy young individuals were excluded from the study since they did not appeared in the second day of evaluation. 3 COPD patient Analysis Population Description: s and 5 elderly subjects didn't show on the third day of evaluation, then, they were just excluded in the analysis of the variables collected in this day.

ArmMeasureValue (MEAN)Dispersion
Healthy Young SubjectsThird Six Minute Walk Test Heart Rate145 bpmStandard Deviation 10
Healthy Elderly SubjectsThird Six Minute Walk Test Heart Rate112 bpmStandard Deviation 13
COPD PatientsThird Six Minute Walk Test Heart Rate114 bpmStandard Deviation 13
Secondary

Third Six Minute Walk Test Peripheral Oxygen Saturation

This test will be conducted by the Rater 2, the subject will walk as far as it can in a 30m corridor during 6 minutes. It will be evaluated by a pulse oxymeter.

Time frame: On the third day of evaluation, seven days after the first day of evaluation. Since it was performed in the same day of the third 6MST, the choice of the first test was random, and there was a 30 minute interval between them.

Population: 2 COPD patients and 2 healthy young individuals were excluded from the study since they did not appeared in the second day of evaluation. 3 COPD patient Analysis Population Description: s and 5 elderly subjects didn't show on the third day of evaluation, then, they were just excluded in the analysis of the variables collected in this day.

ArmMeasureValue (MEAN)Dispersion
Healthy Young SubjectsThird Six Minute Walk Test Peripheral Oxygen Saturation96.1 % of hemoglobinStandard Deviation 1.6
Healthy Elderly SubjectsThird Six Minute Walk Test Peripheral Oxygen Saturation94.7 % of hemoglobinStandard Deviation 2
COPD PatientsThird Six Minute Walk Test Peripheral Oxygen Saturation89.7 % of hemoglobinStandard Deviation 3.3

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026